Featured Insights

  1. Navigating Commercial Logistics: Key Considerations For Emerging CGT Manufacturers 8/27/2025

    A successful cell and gene therapy launch requires a logistics strategy that keeps patients at the center, plans for disruptions, and prepares for future growth and global expansion.

  2. Discover The Path To Oncology Success 8/22/2025

    The oncology landscape is brimming with innovative therapies and new treatment approaches. Successful commercialization requires a well-orchestrated strategy to bring these complex products to market.

  3. Optimizing Commercial Distribution As You Prepare To Launch Your CGT 7/29/2025

    An effective commercial distribution strategy is crucial for new cell and gene therapies, helping manufacturers navigate challenges and ensure patient access.

  4. Creating A Compliant And Scalable CGT Logistics Launch Plan 6/12/2025

    As cell and gene therapies advance to commercialization, biopharma companies face immense logistical hurdles. A customized, end-to-end strategy is crucial for ensuring product integrity and market success.

  5. ThinkLive Cell and Gene Therapy Summit 2025 Summary 6/11/2025

    From patient support to intricate logistics, ThinkLive CGT Summit 2025 leaders tackled the essential commercial strategies needed to deliver these innovative therapies to patients globally.

  6. Navigating Regulatory Complexity In CGT Development, Commercialization 5/28/2025

    To successfully commercialize cell and gene therapies, understanding evolving US regulatory mandates is key. Consider these strategies to avoid delays and ensure compliance.

  7. Addressing Market Access Challenges As CGTs Expand To Larger Patient Populations 5/1/2025

    Navigating market access for advanced therapies requires new strategies. Explore ways to boost payer understanding, innovate pricing, and adapt treatment settings as these therapies expand.

  8. The Future Promise Of Advanced Therapies In Ophthalmology 3/17/2025

    Six years after the first approved gene therapy in ophthalmology, the field is experiencing a surge of activity. Delve into the exciting potential of advanced therapies for eye diseases.

  9. Navigating Patient Access Challenges When Bringing Your CGT Product To Market 2/24/2025

    Bringing cell and gene therapies to market requires more than scientific breakthroughs; manufacturers must navigate complex patient access challenges to ensure these innovations reach those in need.

  10. Optimizing The Channel Strategy To Expand Patient Access 1/17/2025

    Patient access depends on a well-planned channel strategy. Explore key considerations for optimizing distribution, logistics, and patient support in the evolving cell and gene therapy landscape.